TechDev

Oddifact is a French TechBio company that specializes in transforming off-label uses of existing drugs into authorized treatments for rare disease patients. The company utilizes its proprietary AI-enabled platform, S.A.V.E., to identify promising off-label opportunities from real-world medical practice and convert them into comprehensive 'Orphan Programs.' These programs, which include orphan drug designations, clinical evidence, and regulatory strategies, are then licensed to pharmaceutical partners for commercialization. Oddifact has established itself as a prolific generator of FDA Orphan Drug Designations, offering a de-risked and accelerated alternative to traditional drug development.